HARROW HEALTH, INC. IMMY Income Statement

Harrow health, inc. (IMMY)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues:
Total revenues
11,817	12,604	12,755	13,516	12,290	11,384	10,739	10,384	8,865	-	6,483	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales, net
-	-	-	-	-	-	-	-	-	-	-	6,849	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License revenues
-	-	-	-	-	-	-	-	-	-	-	8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total revenues
-	-	-	-	-	-	-	-	-	-	-	6,857	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of sales
3,626	3,565	4,061	5,225	3,898	4,102	4,191	4,157	4,071	-	3,403	3,288	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales, net
-	-	-	-	-	-	-	-	-	-	-	-	6,089	5,786	4,858	4,902	4,381	3,493	2,682	1,917	1,562	549	439	664	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-
License revenues
-	-	-	-	-	-	-	-	-	-	-	-	8	7	3	5	0	10	1	50	1	1	2	3	2	2	2	2	2	0	0	0	100	0	0	0	0	-	-
Total revenues
-	-	-	-	-	-	-	-	-	-	-	-	6,097	5,793	4,861	4,907	4,381	3,503	2,683	1,967	1,563	550	441	667	2	-	2	2	-	-	-	-	-	-	-	-	-	-	-
Cost of sales
-	-	-	-	-	-	-	-	-	-	-	-	3,357	3,071	2,339	2,172	2,249	1,947	1,202	1,050	1,007	378	239	476	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Gross profit
8,191	9,039	8,694	8,291	8,392	7,282	6,548	6,227	4,794	3,880	3,080	3,569	2,740	2,722	2,522	2,735	2,132	1,556	1,481	917	556	172	202	191	2	-	2	2	-	-	-	-	-	-	-	-	-	-	-
Operating expenses:
Selling and marketing
-	-	-	-	-	-	-	-	-	-	-	-	-	1,415	1,797	2,270	1,900	2,041	1,813	1,630	1,012	902	637	469	382	-	0	0	-	-	-	-	-	-	-	-	-	-	-
General and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	4,214	5,018	4,397	3,940	4,177	3,104	2,743	2,480	1,949	1,954	2,289	1,895	-	1,622	1,556	-	-	-	-	-	-	-	-	-	-	-
Selling, general and administrative
8,416	7,697	8,608	8,248	8,543	9,012	6,964	6,779	6,488	5,942	5,781	6,485	6,811	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,019	740	946	984	308	313	66	121	326	584	409
Research and development
403	424	444	810	405	433	233	72	87	89	63	101	160	601	16	76	46	33	93	25	181	71	70	36	60	14	469	677	455	718	303	133	142	0	0	24	87	142	86
Impairment and disposal of long-lived assets
-	-	4,040	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
8,819	8,121	13,092	9,058	8,948	9,445	7,197	6,851	6,575	-	5,844	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of long-lived assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	303	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of intangible assets and goodwill
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
-	-	-	-	-	-	-	-	-	-	-	6,586	6,971	6,230	7,134	6,743	5,886	6,251	5,010	4,398	3,673	2,922	2,661	2,794	2,337	1,895	2,092	2,233	1,475	-	-	-	-	-	-	-	-	-	-
Loss from operations
-628	918	-4,398	-767	-556	-2,163	-649	-624	-1,781	-2,151	-2,764	-3,017	-4,231	-3,508	-4,612	-4,008	-3,754	-4,695	-3,529	-3,481	-3,117	-2,750	-2,459	-2,603	-2,335	-1,893	-2,089	-2,230	-1,472	-1,458	-1,250	-1,118	-351	-313	-66	-145	-413	-727	-496
Other income (expense):
Interest expense, net
-560	-561	-620	-716	-603	-689	-705	-671	-663	-678	-793	-767	-788	-782	-732	-631	-629	-429	-423	-249	-7	5	7	7	10	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on sale of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12	7	-	4	-	-	-	-	-	-	-	-
Debt extinguishment loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-189	-1,006	0	0	0	0	0	26
Change in fair value of derivative liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	113	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment losses
-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on deconsolidation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on sale of assets
-	-	-	-	-	-	-	-	-	-	-42	-269	-15	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on settlement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
Gain on forgiveness of liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	-	-	-	-	-	-	-
Gain on forgiveness of liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	60	0	0	0	-	-
Other expense, net
-	-	-	-	-	-	-	-	-	-	884	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-12	-7	-5	-4	187	1,027	-41	18	18	18	18	-8
Other income (expense), net
-	0	0	0	630	-	-	-255	-	-	-	-	-	-	1,494	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	3	21	18	18	18	18	18	17
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12	-	-	-	-	5	0	0	0	0	0	0	0
Total other (expense) income, net
-12,295	1,674	-7,232	-1,653	11,889	20,293	-1,865	3,146	-1,732	-1,471	-2,956	4,473	-803	-2,705	762	-631	-742	-429	-423	-249	24	5	7	7	10	-	12	-	-	-	-	-	-	-	-	-	-	-	-
(Loss) income before income taxes
-12,923	-	-	-	11,333	-	-	-	-	-3,622	-5,720	1,456	-5,034	-6,213	-3,850	-4,639	-4,496	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	31	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax benefit, net
-	-	-	-	-	-	-	-	-	-851	-28	-28	-28	-111	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total net (loss) income including noncontrolling interests
-12,923	2,592	-11,630	-2,420	11,333	18,130	-2,514	2,522	-3,513	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to noncontrolling interests
16	65	161	42	25	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net (loss) income attributable to Harrow Health, Inc.
-12,907	2,657	-11,469	-2,378	11,358	18,130	-2,514	2,522	-3,513	-2,771	-5,692	1,484	-5,006	-6,102	-3,850	-4,639	-4,496	-5,124	-3,952	-3,730	-3,093	-2,745	-2,452	-2,596	-2,325	-1,882	-2,077	-2,218	-1,465	-1,453	-1,245	-1,305	-1,379	-271	-85	-164	-432	-746	-488
Basic net (loss) income per share of common stock
-0.50	-	-	-0.09	0.46	-	-	0.12	-0.17	-	-	0.07	-	-	-	-0.35	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted net (loss) income per share of common stock
-0.50	-	-	-0.09	0.43	-	-	0.11	-0.17	-	-	0.06	-	-	-	-0.35	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average number of shares of common stock outstanding, basic
25,867	-	-	25,216	24,841	-	-	21,190	20,949	-	-	20,209	-	-	-	13,332	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average number of shares of common stock outstanding, diluted
25,867	-	-	25,216	26,589	-	-	23,175	20,949	-	-	23,177	-	-	-	13,332	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deemed dividend to preferred stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	200	0	100	0	0	0	-	-
Net loss attributable to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,465	-1,453	-1,245	-1,505	-1,379	-371	-85	-164	-432	-	-
Basic and diluted net loss per share of common stock
-	-	-0.45	-	-	-	-0.12	-	-	-	-0.28	-	-0.26	-	-0.29	-	-0.43	-0.53	-0.41	-0.39	-0.33	-0.30	-0.27	-0.28	-0.26	-0.21	-0.23	-0.25	-0.19	0.65	-0.20	-0.39	-1.30	-2.31	-0.04	-0.08	-0.22	-0.05	-0.03
Weighted average number of shares of common stock outstanding, basic and diluted
-	-	25,583	-	-	-	21,709	-	-	-	20,273	-	18,927	-	13,471	-	10,407	9,862	9,603	9,501	9,337	9,257	9,154	9,109	9,010	8,986	8,961	8,890	7,788	6,816	6,219	3,874	1,063	-	1,987	-	-	-	-
Weighted average common shares outstanding, basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,989	1,991	15,859	15,703
Sales, Net [Member]
Total revenues
11,810	12,597	12,748	13,509	12,283	11,376	10,729	10,374	8,855	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License Revenues [Member]
Total revenues
7	7	7	7	7	8	10	10	10	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Melt Pharmaceuticals [Member]
Investment (loss) gain, net
-546	-549	-682	-326	5,525	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Surface Pharmaceuticals [Member]
Investment (loss) gain, net
-339	-296	-400	-261	-243	-	-128	5,218	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Eton Pharmaceuticals [Member]
Investment (loss) gain, net
-10,850	3,080	-5,530	-350	6,580	21,160	-1,032	-1,146	-1,069	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-